NABUCOX Side Effects

6836047-5 | Purpura
on Jul 05, 2010 Male patient from FRANCE , 78 years of age, was diagnosed with sciatica (What is sciatica?) and was treated with Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: purpura. Nabucox dosage: 500mg Four Times Per Day. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6831485-9 | Cytolytic Hepatitis
Patient was taking Nabucox (View Usage). Patient had the following side effects: cytolytic hepatitis on Jul 02, 2010 from FRANCE Additional patient health information: Female patient , 67 years of age, . Nabucox dosage: 500mg Twice Per Day. During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), IXPRIM (View Ixprim Review and Ixprim Label ), EFFEXOR (View Effexor Review and Effexor Label ).

6236556-6 | Muscle Contractions Involuntary, Pruritus
Adverse event was reported on Jun 16, 2009 by a Male patient taking Nabucox (View Usage) (Dosage: 2tab Twice Per Day) . Location: FRANCE , 49 years of age, After Nabucox was administered, patient had the following side effects: muscle contractions involuntary, pruritus. During the same period patient was treated with THIOCOLCHICOSIDE (4mg Twice Per Day) (View Thiocolchicoside Review and Thiocolchicoside Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6139780-6 | Abdominal Pain Upper, Fatigue, Gamma-glutamyltransferase Increased, Transaminases Increased, Weight Decreased
on Apr 01, 2009 Female patient from FRANCE , 55 years of age, was treated with Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, fatigue, gamma-glutamyltransferase increased, transaminases increased, weight decreased. Nabucox dosage: 500mg Twice Per Day. During the same period patient was treated with PIASCLEDINE (300mg Per Day) (View Piascledine Review and Piascledine Label ), EUPANTOL (20mg Per Day) (View Eupantol Review and Eupantol Label ), METHOCARBAMOL (500mg Twice Per Day) (View Methocarbamol Review and Methocarbamol Label ), TETRAZEPAM (50mg Per Day) (View Tetrazepam Review and Tetrazepam Label ), EFFERALGAN (2tab Per Day) (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.


6138276-5 | Blood Amylase Increased, Dermatitis, Eczema, Prurigo, Skin Reaction
on Mar 27, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?), malaria prophylaxis and was treated with Nabucox (View Usage). Patient had the following side effects: blood amylase increased, dermatitis, eczema (What is eczema?), prurigo, skin reaction. Nabucox dosage: 1.5tab Per Day. During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ), NEXIUM (40mg Four Times Per Day) (View Nexium Review and Nexium Label ), CRESTOR (10mg Four Times Per Day) (View Crestor Review and Crestor Label ), MALARONE (View Malarone Review and Malarone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SKENAN (View Skenan Review and Skenan Label ). Patient was hospitalized.

6115050-7 | Abdominal Pain Upper, Fatigue, Gamma-glutamyltransferase Increased, Transaminases Increased, Weight Decreased
Patient was taking Nabucox (View Usage). After Nabucox was administered, patient had the following side effects: abdominal pain upper, fatigue, gamma-glutamyltransferase increased, transaminases increased, weight decreased on Mar 12, 2009 from FRANCE Additional patient health information: Female patient , 55 years of age, . Nabucox dosage: 500mg Twice Per Day. During the same period patient was treated with PIASCLEDINE (300mg Per Day) (View Piascledine Review and Piascledine Label ), EUPANTOL (20mg Per Day) (View Eupantol Review and Eupantol Label ), METHOCARBAMOL (500mg Twice Per Day) (View Methocarbamol Review and Methocarbamol Label ), TETRAZEPAM (50mg Per Day) (View Tetrazepam Review and Tetrazepam Label ), EFFERALGAN (2tab Per Day) (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.

5647023-2 | Anaemia, Bone Marrow Toxicity, Cardiac Arrest, Cytolytic Hepatitis, Haematoma, Histiocytosis Haematophagic, Inflammation, Lung Disorder, Pain
Adverse event was reported on Feb 25, 2008 by a Male patient taking Nabucox (View Usage) (Dosage: ) . Location: FRANCE , 57 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, bone marrow toxicity, cardiac arrest (What is cardiac arrest?), cytolytic hepatitis, haematoma, histiocytosis haematophagic, inflammation, lung disorder, pain (What is pain?). During the same period patient was treated with PROFENID (View Profenid Review and Profenid Label ), ACUPAN (View Acupan Review and Acupan Label ), MIOREL (View Miorel Review and Miorel Label ), NUROFEN (View Nurofen Review and Nurofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ZALDIAR (View Zaldiar Review and Zaldiar Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ), EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ). Patient was hospitalized.

5632105-1 | Abdominal Pain Upper, Fatigue, Gamma-glutamyltransferase Increased, Transaminases Increased, Weight Decreased
on Feb 14, 2008 Female patient from FRANCE , 55 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Nabucox (View Usage). Patient had the following side effects: abdominal pain upper, fatigue, gamma-glutamyltransferase increased, transaminases increased, weight decreased. Nabucox dosage: 500mg Twice Per Day. During the same period patient was treated with PIASCLEDINE (300mg Per Day) (View Piascledine Review and Piascledine Label ), EUPANTOL (20mg Per Day) (View Eupantol Review and Eupantol Label ), METHOCARBAMOL (500mg Twice Per Day) (View Methocarbamol Review and Methocarbamol Label ), TETRAZEPAM (50mg Per Day) (View Tetrazepam Review and Tetrazepam Label ), EFFERALGAN (2tab Per Day) (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.

5118642-7 | Abdominal Pain, Hyponatraemia, Vomiting
on Sep 26, 2006 Female patient from FRANCE , 77 years of age, was treated with Nabucox (View Usage). After Nabucox was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), hyponatraemia, vomiting. Nabucox dosage: . During the same period patient was treated with ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ). Patient was hospitalized.

4889636-1 | Angioneurotic Oedema, Face Oedema, Localised Oedema
Patient was taking Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: angioneurotic oedema, face oedema, localised oedema on Jan 16, 2006 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with back pain (What is back pain?) and. Nabucox dosage: 1g Twice Per Day. During the same period patient was treated with NSAIDS (View Nsaids Review and Nsaids Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), MEDIATOR (View Mediator Review and Mediator Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

4881973-X | Angioneurotic Oedema, Face Oedema, Localised Oedema
Adverse event was reported on Jan 16, 2006 by a Male patient taking Nabucox (View Usage) (Dosage: 1g Twice Per Day) was diagnosed with back pain (What is back pain?) and. Location: FRANCE , 52 years of age, Patient had the following side effects: angioneurotic oedema, face oedema, localised oedema. During the same period patient was treated with NSAIDS (View Nsaids Review and Nsaids Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), MEDIATOR (View Mediator Review and Mediator Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

4871812-5 | Anorexia, Chromaturia, Faeces Discoloured, Hepatitis, Hepatitis Cholestatic, Weight Decreased
on Dec 29, 2005 Female patient from FRANCE , 63 years of age, was treated with Nabucox (View Usage). After Nabucox was administered, patient had the following side effects: anorexia, chromaturia, faeces discoloured, hepatitis (What is hepatitis?), hepatitis cholestatic, weight decreased. Nabucox dosage: . During the same period patient was treated with ACTONEL (5mg Per Day) (View Actonel Review and Actonel Label ), CIPROFIBRATE (100mg Per Day) (View Ciprofibrate Review and Ciprofibrate Label ), DELURSAN (250mg Twice Per Day) (View Delursan Review and Delursan Label ), DIOSMINE (600mg Per Day) (View Diosmine Review and Diosmine Label ), NEXIUM (View Nexium Review and Nexium Label ), PERIDYS (View Peridys Review and Peridys Label ). Patient was hospitalized.

4847238-7 | Conjunctival Haemorrhage
on Sep 06, 2005 Female patient from FRANCE , 77 years of age, was diagnosed with blepharitis, conjunctivitis and was treated with Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival haemorrhage. Nabucox dosage: 1g Per Day. During the same period patient was treated with MOPRAL (View Mopral Review and Mopral Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), TIMACOR (View Timacor Review and Timacor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CHIBRO CADRON (View Chibro-cadron Review and Chibro-cadron Label ), STERDEX (View Sterdex Review and Sterdex Label ).

4847237-5 | Erythema Multiforme, Skin Disorder, Skin Lesion
Patient was taking Nabucox (View Usage). Patient had the following side effects: erythema multiforme, skin disorder, skin lesion on Sep 06, 2005 from FRANCE Additional patient health information: Male patient , 73 years of age, . Nabucox dosage: 1g Per Day. During the same period patient was treated with NEURIPLEGE (View Neuriplege Review and Neuriplege Label ), PANOS (50mg Per Day) (View Panos Review and Panos Label ). Patient was hospitalized.

4847235-1 | Anaphylactoid Reaction, Bronchospasm, Erythema, Eye Disorder
Adverse event was reported on Aug 12, 2005 by a Male patient taking Nabucox (View Usage) (Dosage: 1g Twice Per Day) . Location: FRANCE , 78 years of age, After Nabucox was administered, patient had the following side effects: anaphylactoid reaction, bronchospasm, erythema, eye disorder. During the same period patient was treated with LYSOPAINE (1200iu Per Day) (View Lysopaine Review and Lysopaine Label ), PARACETAMOL + DEXTROPROPOXYPHENE (430mg Six Times Per Day) (View Paracetamol + Dextropropoxyphene Review and Paracetamol + Dextropropoxyphene Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LYSINE ASPIRIN (View Lysine Aspirin Review and Lysine Aspirin Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ). Patient was hospitalized.

4847234-X | Blood Pressure Increased
on Aug 01, 2005 Male patient from FRANCE , 70 years of age, was treated with Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Nabucox dosage: . Patient was hospitalized.

4845306-7 | Oliguria, Renal Failure Acute, Vomiting
on Sep 06, 2005 Female patient from FRANCE , 21 years of age, was treated with Nabucox (View Usage). Patient had the following side effects: oliguria, renal failure acute, vomiting. Nabucox dosage: 1g Twice Per Day. Patient was hospitalized.

4768746-3 | Conjunctival Haemorrhage
Patient was taking Nabucox (View Usage). After Nabucox was administered, patient had the following side effects: conjunctival haemorrhage on Sep 06, 2005 from FRANCE Additional patient health information: Female patient , 77 years of age, . Nabucox dosage: 1g Four Times Per Day.

4768735-9 | Eosinophilia, Pyrexia, Rash Maculo-papular, Toxic Skin Eruption
Adverse event was reported on Jul 28, 2005 by a Female patient taking Nabucox (View Usage) (Dosage: 1g Twice Per Day) was diagnosed with osteoarthritis (What is osteoarthritis?) and. Location: FRANCE , 58 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, pyrexia, rash maculo-papular, toxic skin eruption. During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), CELECOXIB (200mg Per Day) (View Celecoxib Review and Celecoxib Label ), CYCLO 3 FORT (400mg Twice Per Day) (View Cyclo 3 Fort Review and Cyclo 3 Fort Label ), ART 50 (50mg Twice Per Day) (View Art 50 Review and Art 50 Label ). Patient was hospitalized.

4746739-X | Anaphylactoid Reaction, Bronchospasm, Erythema, Eye Disorder
on Aug 12, 2005 Male patient from FRANCE , 78 years of age, was treated with Nabucox (View Usage). Patient had the following side effects: anaphylactoid reaction, bronchospasm, erythema, eye disorder. Nabucox dosage: 2g Per Day. During the same period patient was treated with LYSOPAINE (1200iu Per Day) (View Lysopaine Review and Lysopaine Label ), PARACETAMOL + DEXTROPROPOXYPHENE (430mg Six Times Per Day) (View Paracetamol + Dextropropoxyphene Review and Paracetamol + Dextropropoxyphene Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LYSINE ASPIRIN (View Lysine Aspirin Review and Lysine Aspirin Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ). Patient was hospitalized.

4730204-X | Eosinophilia, Pyrexia, Rash Maculo-papular, Toxic Skin Eruption
on Jul 28, 2005 Female patient from FRANCE , 58 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Nabucox (View Usage). After Nabucox was administered, patient had the following side effects: eosinophilia, pyrexia, rash maculo-papular, toxic skin eruption. Nabucox dosage: 2g Per Day. During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), CELECOXIB (200mg Per Day) (View Celecoxib Review and Celecoxib Label ), CYCLO 3 FORT (400mg Twice Per Day) (View Cyclo 3 Fort Review and Cyclo 3 Fort Label ), ART 50 (50mg Twice Per Day) (View Art 50 Review and Art 50 Label ). Patient was hospitalized.

4546530-3 | Anaemia, Asthenia, Duodenal Ulcer, Helicobacter Pylori Identification Test Positive, Melaena, Muscular Weakness, Pallor
Patient was taking Nabucox (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, duodenal ulcer, helicobacter pylori identification test positive, melaena, muscular weakness, pallor on Dec 28, 2004 from Additional patient health information: Female patient , 39 years of age, was diagnosed with back pain (What is back pain?) and. Nabucox dosage: 1g Per Day. During the same period patient was treated with PARACETAMOL + TRAMADOL (View Paracetamol + Tramadol Review and Paracetamol + Tramadol Label ), LESCOL (View Lescol Review and Lescol Label ), BIOTINE (View Biotine Review and Biotine Label ). Patient was hospitalized.

4543610-3 | Arthralgia, Erythema Nodosum, Pyrexia
Adverse event was reported on Dec 10, 2004 by a Male patient taking Nabucox (View Usage) (Dosage: ) . Location: , 26 years of age, Patient had the following side effects: arthralgia, erythema nodosum, pyrexia. During the same period patient was treated with ISOTRETINOINE (View Isotretinoine Review and Isotretinoine Label ). Patient was hospitalized.